She is a scientist......not an investor in NWBO. She has all the time in the world to get it right....If not NWBO, then another company. Please Flipper, know the difference between INVESTMENTS & SCIENCE.
So you mean that while everything is under embargo for the publication, she could write an article based on generic assumptions of an embargoed publication? Gimme a break.
Flip, the only shorts are likely Cayman friendlies who the company seeks out to partake in financing. What are you suggesting they brace for, another LP/LG special? By that I mean financing at a big discount..
What does Dr. Liau see to be able to make the very recent comment that autologous tumor lysate pulsed dendritic cells (aka: DCVax-L) are the most promising immunotherapy for GBM? Pretty bold.
Flip are you certain that LL is not also working on a more advanced treatment than DCVAX-L that she may have developed more recently in which NWBO is not her sponsor?